Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 1;11(1):e2019032.
doi: 10.4084/MJHID.2019.032. eCollection 2019.

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Valeria Crobu  1 , Giovanni Caocci  2 , Giorgio La Nasa  2 , Laura Saderi  1 , Giovanni Sotgiu  1 , Claudio Fozza  1
Affiliations

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Valeria Crobu et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: Acute Myeloid Leukemia; Clofarabine; Cytarabine; Reinduction.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1
a) Kaplan Mayer survival curves for patients treated in second line in the overall population b) Kaplan Mayer survival curves for patients treated in second line in the population stratified according to their treatment with CLARA or with the control group.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Megias-Vericat JE, Martinez-Cuadron D, Sanz MA, et al. Salvage regimes using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review. Annals of Hematology. 2018;97:1115–1153. doi: 10.1007/s00277-018-3304-y. - DOI - PubMed
    1. Estey E. Acute Myeloid Leukemia: 2016 Update on risk stratification and management. Am J Hematol. 2016;91:825–846. doi: 10.1002/ajh.24439. - DOI - PubMed
    1. Rashidi A, Weisdorf DJ, Bejanyan N. Treatment of relapsed/refractory acute myeloid leukaemia in adults. British journal of Haematology. 2018;181:27–37. doi: 10.1111/bjh.15077. - DOI - PubMed
    1. Bose P, Vachhani P, Cortes JE. Treatment of Relapsed/Refractory Acute Myeloid Leukemia. Curr Treat Options Oncol. 2017;18(3):17. doi: 10.1007/s11864-017-0456-2. - DOI - PubMed
    1. Fozza C. The role of Clofarabine in the treatment of adults with acute myeloid leukemia. Crit Rev Oncol Hematol. 2015;93:237–45. doi: 10.1016/j.critrevonc.2014.10.009. - DOI - PubMed